Direct communication with healthcare professionals on Integrilin (eptifibatide)

Asset Publisher

Direct communication with healthcare professionals on Integrilin (eptifibatide)

Cessation of production of Integrilin with immediate effect.

Published on: 02 November 2023

Asset Publisher

Site Map

Access to medicinal products

Share

Nested Applications

Highlights

30/12/2024 - AIFA President Nisticò: “With the approval of the single role for scientific officers, high-profile professionals who are strategic for the proper functioning of the Agency are secured”

16/12/2024 - AIFA launches crackdown on conflict of interest. But opens the way for free opinions and consultations by high-profile professionals

ALL NEWS

News

14/01/2025

Hepatitis C: update of 13 January 2025 concerning enrolled patients

13/01/2025

Innovative medicines list: AIFA publishes December 2024 update

07/01/2025

List of class A and H medicinal products at 17 June 2024

All news

Galleria

Nested Applications

Press

AIFA President Nisticò: “With the approval of the single role for scientific officers, high-profile professionals who are strategic for the proper functioning of the Agency are secured”

Aifa toggle bar Search

Aifa toggle bar Search

Direct communication with healthcare professionals on Integrilin (eptifibatide) - Direct communication with healthcare professionals on Integrilin (eptifibatide)

Asset Publisher

Asset Publisher

Direct communication with healthcare professionals on Integrilin (eptifibatide)

Asset Publisher

Related documents

Site Map

Access to medicinal products

Share

Nested Applications

Highlights

30/12/2024 - AIFA President Nisticò: “With the approval of the single role for scientific officers, high-profile professionals who are strategic for the proper functioning of the Agency are secured”

16/12/2024 - AIFA launches crackdown on conflict of interest. But opens the way for free opinions and consultations by high-profile professionals

ALL NEWS

News

Galleria

Nested Applications

Press

AIFA President Nisticò: “With the approval of the single role for scientific officers, high-profile professionals who are strategic for the proper functioning of the Agency are secured”

All press releases

Last tweets

Go to Twitter profile

Go to Twitter profile

Multimedia

Spot 2024

Go to YouTube channel

Cookie Bar

Descrizione cookieBar

Footer

The agency

Contacts

FOLLOW US ON

FEED RSS

COOKIES

Language Selector

Language Selector

Aifa toggle bar Search

Direct communication with healthcare professionals on Integrilin (eptifibatide) - Direct communication with healthcare professionals on Integrilin (eptifibatide)

Breadcrumb

Asset Publisher

Asset Publisher

Direct communication with healthcare professionals on Integrilin (eptifibatide)

Asset Publisher

Related documents

Site Map

Access to medicinal products

Share

Nested Applications

Highlights

30/12/2024 - AIFA President Nisticò: “With the approval of the single role for scientific officers, high-profile professionals who are strategic for the proper functioning of the Agency are secured”

16/12/2024 - AIFA launches crackdown on conflict of interest. But opens the way for free opinions and consultations by high-profile professionals

ALL NEWS

News

Galleria

Nested Applications

Press

AIFA President Nisticò: “With the approval of the single role for scientific officers, high-profile professionals who are strategic for the proper functioning of the Agency are secured”

All press releases

Last tweets

Go to Twitter profile

Go to Twitter profile aifa_ufficiale

Multimedia

Spot 2024

Go to YouTube channel

Cookie Bar

cookie management module

Descrizione cookieBar

Footer

The agency

Contacts

FOLLOW US ON

FEED RSS

COOKIES

Sezione Link Utili

Go to Twitter profile